IP Library › Granted Patent US 12,523,631
Granted Patent B2
US 12,523,631 · App. 17/916,647 · Granted Jan 13, 2026

Genome integrity analysis of adeno-associated virus vectors

Inventors: Handy Yowanto (Walnut, CA); Elliot B. Jones (Redwood City, CA); Jane Luo (Brea, CA)
Assignee: DH TECHNOLOGIES DEVELOPMENT PTE. LTD.
G01N27/44721C12N9/22C12N9/50C12N15/101C12Q1/70G01N27/44782C12N2750/14141C12Y304/21064
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,523,631
App. No.
17/916,647
Granted
Jan 13, 2026
Kind
B2
Abstract

A CE based method and kit for the determination of the size and purity of an AAV genome which relies on Capillary Electrophoresis-Laser Induced Fluorescence (CE-LIF) analysis. These methods and kits are capable of detecting intact and partial genomes in a virus vectors such as adeno-associated viruses as well as remove small size impurities. In one example, the method can include creating a nucleic acid ladder using CE-LIF, releasing the genome from within an adeno-associated virus, purifying said genome and analyzing said genome using CE-LIF and comparing the results of the analysis of the genome to the nucleic acid ladder to determine a size of nucleic acids in the genome.

Claims (21)

1 . A kit for analyzing an adeno-associated virus comprising:

a standard comprising a plurality of different ssRNA strands, each of the different ssRNA strands having a known and different size;

a positive control containing an intact AAV genome, a partial AAV genome and small size impurities; and

a separation matrix adapted for use with capillary electrophoresis.

2 . The kit of claim 1 further comprising enzymes to digest nucleic acids.

3 . The kit of claim 2 wherein the enzymes comprises benzonase.

4 . The kit of claim 1 further comprising an enzyme that releases nucleic acid from an adeno-associated virus.

5 . The kit of claim 4 wherein said enzyme is Proteinase K.

6 . The kit of claim 1 further comprising materials adapted to perform a PCR purification.

7 . A method for analyzing a genome of an adeno-associated virus in a sample comprising:

creating a standard comprising a number of different nucleic acid strands, each of the different nucleic acid strands having a known size, wherein the nucleic acid strands are ssRNA;

separating each of the different nucleic acid strands in the standard by measuring each of the nucleic acid strands having a known size by utilizing a capillary electrophoresis-laser induced fluorescence (CE-LIF) device and measuring the separated nucleic acid strands as intensity peaks that are a function of migration time using a detector of the CE-LIF;

creating a purified sample by subjecting said sample to purification to remove nucleic acid impurities;

releasing nucleic acid material from the adeno-associated virus in the purified sample by use of an enzyme;

separating and analyzing the released nucleic acid material from the purified sample utilizing the CE-LIF device and measuring the separated nucleic acid strands as one or more intensity peaks that are a function of migration time using a detector of the CE-LIF; and

identifying the size of the nucleic acid material in the sample by comparing the intensities and migration times of the released nucleic acid material from the purified sample and the intensities and migration times of the nucleic acid strands of the standard.

8 . The method of claim 7 wherein the nucleic acid strands of the standard comprise RNA.

9 . The method of claim 7 wherein purification of the samples is performed by digesting the sample with benzonase and isolating the adeno-associated virus by filtration.

10 . The method of claim 7 wherein the enzyme is Proteinase K.

11 . The method of claim 7 wherein the released nucleic acid material is subjected to purification using a PCR purification kit.

12 . The method of claim 7 wherein the nucleic acid material comprises DNA.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2023
From: YOWANTO, HANDY; JONES, ELLIOTT; LUO, JANE
To: DH TECHNOLOGIES DEVELOPMENT PTE. LTD.
Reel/Frame 063922/0588 →
Continuity (2)
Provisional Application 63006012 · Apr 6, 2020
Related Publication 20230132528A1 · May 4, 2023
References Cited (7)
PCT, International Search Report regarding Application No. PCT/IB2021/053863, 11 pages, mailed Aug. 16, 2021. [cited by applicant]
Li, Tingting, et al., “Characterization of Adeno-Associated Virus (AAV) using Capillary Electrophoresis,” PEGS Europe 2019, 1 page, dated Nov. 18, 2019. [cited by applicant]
Xiaotong, Fu, et al., “Analytical Strategies for Quantification of Adeno-Associated Virus Empty Capsids to Support Process Development,” Human Gene Therapy Methods, vol. 30, No. 4, 9 pages, dated Aug. 1, 2019. [cited by applicant]
Lock, Martin, et al., “Absolute Determination of Single-Stranded and Self-Complemen tary Adeno-Associated Viral Vector Genome Titers by Droplet Digitakl PCR”, Human Gene Therapy Methods, vol. 25, No. 2, 11 pages, dated … [cited by applicant]
Schnodt, Maria, et al., “Improving the Quality of Adeno-Associated Viral Vector Preparations: The Challenge of Product-Related Impurities,” Human Gene Therapy Methods, vol. 28, No. 3, 8 pages, dated 0-01-2017. [cited by applicant]
Kaneta, Takashi, “Laser-Induced Fluorometry for Capillary Electrophoresis,” Chemical Record, vol. 19, Nos. 2-3, 10 pages, dated Aug. 6, 2018. [cited by applicant]
Li, Tingting, et al., “Rapid Determination of Full and Empty Adeno-Associated Virus Capsid Ratio by Capillary Isoelectric Focusing,” Current Molecular Medicine, vol. 20., No. 10, 7 pages, dated Feb. 3, 2021. [cited by applicant]